RTW INVESTMENTS, LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001493215

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q3 2023 · 67 positions · Total reported value $4.74B · Top-10 concentration 55.8% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 37.2% · 10 new · 12 cut · 13 exited

Active Share (vs S&P 500): 99.8% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -7.3% · vs SPY -9.4% · Prev Value $11.71B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -1.7% · vs SPY -3.9% · Latest Value $9.91B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2023 13F filing, RTW INVESTMENTS, LP disclosed 67 equity positions with a combined reported value of $4.74B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 55.8% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2023 were RCKT ($362.42M), IMCR ($316.40M), AXSM ($313.78M). By sector, the heaviest allocations are Health Care 73.3%, Industrials 8.9%.

Versus the prior quarter, RTW INVESTMENTS, LP opened 10 new positions, trimmed 12 and fully exited 13, a turnover rate of 37.2% of positions.

The largest new positions opened in Q3 2023 were RCKT ($362.42M), IMCR ($316.40M), AXSM ($313.78M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2023)

  • RCKT ROCKET PHARMACEUTICALS INC · $362.42M
  • IMCR IMMUNOCORE HLDGS PLC · $316.40M
  • AXSM AXSOME THERAPEUTICS INC. · $313.78M
  • ALNY ALNYLAM PHARMACEUTICALS INC · $298.12M
  • MRTX MIRATI THERAPEUTICS INC · $294.84M
  • ARGX ARGENX SE · $249.35M
  • ACAD ACADIA PHARMACEUTICALS INC · $241.26M
  • BRKR BRUKER CORP · $210.68M

Fully Exited (vs previous quarter)

No tracked position was fully exited this quarter.

Insider Transactions (Form 4)

Latest RTW INVESTMENTS, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-11-09 Buy Orchestra BioMed Holdings, Inc. 1,200,000 $5.00 SEC filing
2026-07-21 J ALLURION TECHNOLOGIES, INC. 1,771 — SEC filing
2026-07-21 J ALLURION TECHNOLOGIES, INC. 19,934 — SEC filing
2026-07-21 J ALLURION TECHNOLOGIES, INC. 161,807 — SEC filing
2026-07-21 J ALLURION TECHNOLOGIES, INC. 209,254 — SEC filing
2026-04-27 Sell Orchestra BioMed Holdings, Inc. 32 $4.13 SEC filing
2026-04-27 Opt exercise Orchestra BioMed Holdings, Inc. 1,250,032 $0.00 SEC filing
2026-04-20 Buy Kailera Therapeutics, Inc. 500,000 $16.00 SEC filing

All insider transactions →

Fund Profile

RTW Investments, based in New York, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 84 positions worth $11.71B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-78183 (status: Approved), registered 2013-06-13
  • Regulatory AUM (Form ADV): $14.14B as of 2026-03-30
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 3 private funds, of which 2 hedge funds
  • Website: rtwfunds.com

Portfolio Structure

  • 84 positions · $11.71B reported value (Q2 2026)
  • Top 10 holdings = 47.7% of reported value
  • Largest position: MDGL (MADRIGAL PHARMACEUTICALS INC) at 9.1%
  • Average position size: $139.44M

Sector Tilt

  • Health Care 99.1%
  • Industrials 0.4%
  • Information Technology 0.4%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 9 new, 24 added, 8 reduced, 13 exited
  • 43 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 73.3%
Other 17.9%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 17.69M $362.42M 7.65%
7.65%
New
2 6.10M $316.40M 6.68%
6.68%
New
3 4.49M $313.78M 6.62%
6.62%
New
4 1.68M $298.12M 6.29%
6.29%
New
5 6.77M $294.84M 6.22%
6.22%
New
6 507.19K $249.35M 5.26%
5.26%
New
7 11.58M $241.26M 5.09%
5.09%
New
8 3.38M $210.68M 4.45%
4.45%
New
9 5.41M $192.69M 4.07%
4.07%
New
10 673.37K $162.90M 3.44%
3.44%
New
11 7.24M $162.14M 3.42%
3.42%
New
12 290.33K $146.96M 3.10%
3.10%
New
13 1.50M $131.65M 2.78%
2.78%
New
14 2.49M $122.39M 2.58%
2.58%
New
15 2.65M $117.34M 2.48%
2.48%
New
16 3.29M $110.34M 2.33%
2.33%
New
17 5.15M $105.98M 2.24%
2.24%
New
18 3.46M $95.31M 2.01%
2.01%
New
19 5.42M $90.33M 1.91%
1.91%
New
20 2.57M $75.84M 1.60%
1.60%
New
21 7.14M $73.51M 1.55%
1.55%
New
22 1.52M $62.70M 1.32%
1.32%
New
23 16.89M $53.38M 1.13%
1.13%
New
24 2.88M $51.19M 1.08%
1.08%
New
25 5.62M $49.01M 1.03%
Form 4 · 1 →
1.03%
New
26 1.87M $47.09M 0.99%
0.99%
New
27 2.00M $47.08M 0.99%
0.99%
New
28 2.14M $45.64M 0.96%
0.96%
New
29 309.49K $45.20M 0.95%
0.95%
New
30 6.69M $42.68M 0.90%
0.90%
New
31 3.33M $33.44M 0.70%
0.70%
New
32 500.00K $28.50M 0.60%
0.60%
New
33 5.82M $25.84M 0.55%
0.55%
New
34 188.12K $25.83M 0.55%
0.55%
New
35 889.07K $24.90M 0.53%
0.53%
New
36 442.49K $24.83M 0.52%
0.52%
New
37 124.00K $24.69M 0.52%
0.52%
New
38 3.30M $23.48M 0.49%
0.49%
New
39 1.55M $18.14M 0.38%
0.38%
New
40 4.39M $17.30M 0.36%
0.36%
New
41 3.46M $14.87M 0.31%
0.31%
New
42 500.89K $14.85M 0.31%
0.31%
New
43 2.38M $14.59M 0.31%
0.31%
New
44 857.46K $12.01M 0.25%
0.25%
New
45 1.85M $11.12M 0.23%
0.23%
New
46 3.26M $10.09M 0.21%
0.21%
New
47 978.31K $9.95M 0.21%
0.21%
New
48 845.00K $9.79M 0.21%
0.21%
New
49 808.66K $8.80M 0.19%
0.19%
New
50 922.10K $8.77M 0.18%
0.18%
New

FAQ

What did RTW INVESTMENTS, LP buy in 2023-Q3?

In its 2023-Q3 13F filing, RTW INVESTMENTS, LP reported 67 equity positions worth $4.74B in aggregate; its largest disclosed positions were RCKT ($362.42M), IMCR ($316.40M), AXSM ($313.78M).

How large is RTW INVESTMENTS, LP's portfolio?

RTW INVESTMENTS, LP reported $4.74B of long equity holdings across 67 positions as of 2023-Q3. Top-10 holdings account for 55.8% of reported value.

What is RTW INVESTMENTS, LP's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/rtw-investments/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →